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OA features as they relate to M:L BMD
Medial TF cartilage damage (MRI) KL 3 or 4 Varus
Prevalence Odds ratio Prevalence Odds ratio Prevalence Odds ratio
Overall M:L BMD
Tertile 1
(0.74−1.24)
11/64
(17.2%)
Referent 19/64
(29.7%)
Referent 20/64
(31.3%)
Referent
Tertile 2
(1.24−1.39)
14/21
(66.7%)
9.6
(3.2−29.4)
17/21
(81.0%)
10.1
(3.0−33.9)
16/21
(76.2%)
7.0
(2.3−21.9)
Tertile 3
(1.40−1.71)
12/14
(85.7%)
28.9
(5.6–147.8)
12/14
(85.7%)
14.2
(2.9−69.6)
13/14
(92.9%)
28.6
(3.5–233.8)
p for trend <0.0001 p for trend <0.0001 p for trend <0.0001
Proximal M:L BMD
Tertile 1
(0.74−1.39)
11/68
(16.2%)
Referent 20/68
(29.4%)
Referent 20/68
(29.4%)
Referent
Tertile 2
(1.39−1.53
14/16
(87.5%)
36.3
(7.2–182.5)
13/16
(81.3%)
10.4
(3.2−29.4)
14/16
(87.5%)
16.8
(3.5−80.8)
Tertile 3
(1.54−1.82)
12/15
(80.0%)
20.7
(5.1−85.8)
15/15
(100%)
inﬁnity 15/15
(100%)
inﬁnity
p for trend <0.0001 p for trend <0.0001 p for trend <0.0001
Distal M:L BMD
Tertile 1
(0.73−1.09)
12/59
(20.3%)
Referent 20/59
(33.9%)
Referent 19/59
(32.2%)
Referent
Tertile 2
(1.09−1.17)
13/20
(65.0%)
7.3
(2.4−22.2)
13/20
(65.0%)
9.6
(3.2−29.4)
15/20
(75%)
6.3
(2.0−19.9)
Tertile 3
(1.17−1.57)
12/20
(60.0%)
5.9
(2.0−17.6)
15/20
(75.0%)
28.9
(5.6–147.8)
15/20
(75%)
6.3
(2.0−19.9)
p for trend =0.0011 p for trend <0.0001 p for trend =0.0010
Conclusions: In symptomatic KOA, increased ipsi-compartmental BMD
is most marked in the proximal 1 cm of peri-articular bone but extends
further. Tibial plateau proximal and distal bone behave similarly such that
both are associated with features of KOA. The 3 measures of M:L BMD
provide contrasting information that allow greater insight into the role of
bone in KOA. The attributes of these measures should be explored in
longitudinal settings.
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Purpose: The role of bone lesions in cartilage loss in knee osteoarthritis
(OA) is any area of great interest. Whether the initial lesion in OA occurs
in bone or cartilage remains unclear, as does the local relationship
between cartilage and bone lesions. Specialized MRI techniques afford
an opportunity to explore this issue in the human knee in vivo. The goals
of our study were: (1) to determine the frequency of subchondral bone
lesions within knee joint surface regions without any cartilage lesion; (2) to
determine the frequency of cartilage lesions within knee regions without
any bone lesion; (3) to determine the strength of the relationship between
cartilage and speciﬁc bone lesion severity.
Methods: Participants had knee OA in at least one knee, by deﬁnite
radiographic osteophytes. Knee MR images were acquired using coronal
T1-weighted spin-echo (SE), sagittal fat-suppressed dual-echo turbo SE,
and axial and coronal fat-suppressed T1-weighted 3D-fast low angle shot
(FLASH) sequences. Three regions (anterior, central, and posterior) of
each surface (medial and lateral femoral condyles, medial and lateral
tibial plateaus) were each scored separately for cartilage morphology
(CM, score range 0−6, in which 2 = solitary focal defect 1 cm in width),
subchondral bone edema (BE), bone cysts (BC), and bone attrition (BA)
using the WORMS method.
Results: The dominant knees of 196 participants (mean age 66, BMI 30,
78% women) were studied. Among tibiofemoral regions with CM< 2, the
prevalence of bone lesions ranged from 0−3%. Among regions without
any bone lesions (i.e. BE, BA, and BC=0), the prevalence of CM 2
ranged from 5% to 33%. Results for all medial tibial and femoral regions
are shown in the table. Within each region, among all knees, CM was
moderately to strongly correlated with each of the bone lesions. For
example, in the central medial femoral region, R (Spearman) for CM and
BE was 0.71 (95% CI 0.63, 0.78), for CM and BA 0.66 (95% CI 0.57,
0.73), and for CM and BC 0.43 (95% CI 0.31, 0.54), and in the central
medial tibial region, R for CM and BE was 0.76 (95% CI 0.70, 0.82), for
CM and BA 0.69 (95% CI 0.61, 0.76), and for CM and BC 0.49 (95% CI
0.38, 0.59).
Conclusions: In summary, in regions with healthy cartilage morphology,
the frequency of bone edema lesions, subchondral cysts, and bone
attrition was very low, whereas in regions with no bone lesions, the
frequency of cartilage lesions was substantially higher. These ﬁndings
are in keeping with the possibility that cartilage lesion development
may precede development of these bone lesions. Within each region,
worse cartilage morphology correlated moderately to strongly with greater
severity of each of the bone lesions.
Medial region Knees with CM< 2 Knees with BE, BA, and BC=0
# %BE> 0 %BA> 0 %BC> 0 # %CM 2
Femoral
anterior 110 1% 1% 0% 161 33%
central 98 1% 0% 0% 135 28%
posterior 134 2% 1% 1% 173 24%
Tibial
anterior 153 2% 0% 3% 166 11%
central 107 0% 2% 0% 139 24%
posterior 146 1% 0% 2% 170 16%
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Purpose: Human osteaoarthriits (OA) is a multi-factorial disease that
involves cartilage, bone and synovium. Epidemiological studies have
shown that it was age and sex-dependant, suggesting the importance
of sex hormones in OA pathophysiology. Estradiol (E2) has well known
effects on bone cells but little is known of its action on cartilage. Different
animal models have shown various conclusions on a possible prevention
of OA by E2. This action could be direct on chondrocytes, or through
the bone underlying the articular cartilage. Indeed, there is evidence of
a relationship between bone remodeling and cartilage degradation. Our
goal is to study the effects of E2 on meniscectomy in ovariectomized
C57/bl6 mice, in terms of cartilage loss, proteases expression and apop-
tosis. This ﬁrst part is followed by an ex vivo study on the direct effects
of E2 on cartilage explants.
Methods: 1. Ten week-old C57/Bl6 female mice underwent medial menis-
cectomy (MNX) of the right knee. Ovariectomy (OVX) was performed
followed by subcutaneous injection of E2 (15mg/kg/d), Pamidronate (PAM
30mg/kg/w) or PBS. Saggital sections in the medial compartment of
both femoro-tibial joints were performed at 6 weeks to evaluate cartilage
degradation using a simpliﬁed semi-quantitative OOCHAS OA grading
scale (from 0 to 6) and to measure bone histomorphometric parameters
in the proximal epiphysis of tibias. ADAMTS-4 and ADAMTS-5 expression
were studied in the cartilage by immunohistochemistry and chondrocyte
apoptosis by Tunel assay. 2. We cultured cartilage explants from femoral
heads in the presence of 10−6M & 10−8M E2 for 72 h with or without prior
stimulation with Il-1 for 24 h. The content of glycoaminoglycan (GAG) was
measured in the medium.
Figure 1.
Results: 1. Each group of mice had the same gain of weight during the
study. E2 and PAM prevented the OVX-related bone loss with an increase
of BV/TV. The OOCHAS score in MNX knees was similar regardless to
OVX (3 for both). PAM and E2 in OVX mice lowered the score at 1.7
and 2.2 respectively. MNX was associated with a signiﬁcant increased
expression of ADAMTS 4 and ADAMTS 5 expression. PAM and E2
